Trinity Biotech (TRIB) Non-cash Items (2009 - 2024)

Trinity Biotech has disclosed Non-cash Items across 15 years of filings, most recently posting -$9.3 million for Q4 2024.

• Non-cash Items for Q4 2024 came in at -$9.3 million, down 1.09% year-over-year; the trailing twelve-month figure through Dec 2024 was -$9.3 million (down 1.09% YoY), and the FY2024 annual result was -$9.3 million, down 1.09% from the prior year.
• Non-cash Items came in at -$9.3 million for Q4 2024 at Trinity Biotech, down from -$9.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $24.7 million in Q4 2020 to a low of -$11.8 million in Q3 2023.
• The 5-year median for Non-cash Items is $1.1 million (2020), against an average of $2.8 million.
• Across the five-year window, Non-cash Items jumped 419831.91% in 2020 and slumped 1316.98% in 2023, its largest moves.
• Trinity Biotech's Non-cash Items stood at $24.7 million in 2020, then plunged by 46.34% to $13.2 million in 2021, then tumbled by 94.3% to $754000.0 in 2022, then plunged by 1316.98% to -$9.2 million in 2023, then dropped by 1.09% to -$9.3 million in 2024.
• The last three Non-cash Items figures came in at -$9.3 million (Q4 2024), -$9.2 million (Q4 2023), and -$11.8 million (Q3 2023), per Business Quant data.